Outcome of Board Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sattva Sukun Lifecare Ltd's board approved audited standalone and consolidated financial results for Q4 and FY26, with an unmodified (clean) opinion from auditor SSRV & Associates. On a standalone basis, FY26 revenue declined ~20% to Rs 422.22 lacs from Rs 526.30 lacs, while the company slipped into a net loss of Rs 13.60 lacs compared to a profit of Rs 69.76 lacs last year; Q4 standalone showed a loss of Rs 56.97 lacs versus a profit of Rs 84.22 lacs a year ago. On a consolidated basis (now including two subsidiaries), total revenue jumped to Rs 3,813.41 lacs but profit after tax fell sharply to Rs 21.17 lacs from Rs 248.94 lacs, with Q4 consolidated net loss at Rs 70.99 lacs. Total expenses surged from Rs 247.91 lacs to Rs 420.78 lacs on a standalone basis, squeezing margins heavily, while operating cash flow turned sharply negative at Rs (473.30) lacs standalone and Rs (1,434.02) lacs consolidated. The company also disclosed that during FY26 it allotted ~19.16 crore equity shares via a rights issue and utilized Rs 1,860.36 lacs of the Rs 1,916.16 lacs raised, with no deviation from stated objects.
A sharp drop in profitability on a standalone basis, expansion into negative net loss territory in Q4, significantly negative operating cash flows, and a steep rise in total expenses will likely weigh negatively on stock sentiment. However, the consolidation now reflects the recently added subsidiaries, and a clean (unmodified) auditor opinion with rights issue funds being used on stated objects provides some comfort.